Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment.

Heiska L, Melikova M, Zhao F, Saotome I, McClatchey AI, Carpén O.

Oncogene. 2011 Dec 15;30(50):4953-62. doi: 10.1038/onc.2011.207.

PMID:
21666723
2.

Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.

Mak H, Naba A, Varma S, Schick C, Day A, SenGupta SK, Arpin M, Elliott BE.

BMC Cancer. 2012 Mar 7;12:82. doi: 10.1186/1471-2407-12-82.

3.

A novel role for ezrin in breast cancer angio/lymphangiogenesis.

Ghaffari A, Hoskin V, Szeto A, Hum M, Liaghati N, Nakatsu K, LeBrun D, Madarnas Y, Sengupta S, Elliott BE.

Breast Cancer Res. 2014 Sep 18;16(5):438. doi: 10.1186/s13058-014-0438-2. Erratum in: Breast Cancer Res. 2015;17:9. LeBrun, David [added].

4.

The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.

Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M.

Breast Cancer Res. 2005;7(3):R365-73.

5.

Src-dependent ezrin phosphorylation in adhesion-mediated signaling.

Srivastava J, Elliott BE, Louvard D, Arpin M.

Mol Biol Cell. 2005 Mar;16(3):1481-90.

7.

Co-operative effect of c-Src and ezrin in deregulation of cell-cell contacts and scattering of mammary carcinoma cells.

Elliott BE, Qiao H, Louvard D, Arpin M.

J Cell Biochem. 2004 May 1;92(1):16-28.

PMID:
15095400
8.
9.
10.

Androgen induction of prostate cancer cell invasion is mediated by ezrin.

Chuan YC, Pang ST, Cedazo-Minguez A, Norstedt G, Pousette A, Flores-Morales A.

J Biol Chem. 2006 Oct 6;281(40):29938-48.

11.

MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.

Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M.

Oncogene. 2011 Aug 11;30(32):3489-501. doi: 10.1038/onc.2011.63.

PMID:
21383697
12.

Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.

Jiang LQ, Feng X, Zhou W, Knyazev PG, Ullrich A, Chen Z.

Oncogene. 2006 Sep 7;25(40):5495-506.

PMID:
16636672
13.

Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation.

Karni R, Gus Y, Dor Y, Meyuhas O, Levitzki A.

Mol Cell Biol. 2005 Jun;25(12):5031-9.

14.

Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate.

Lee JY, Chang JW, Yang WS, Kim SB, Park SK, Park JS, Lee SK.

Am J Physiol Renal Physiol. 2011 May;300(5):F1214-22. doi: 10.1152/ajprenal.00710.2010.

15.

Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.

Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, Liu P, Song A, Gang C, Han Z, Zhou J, Meng L, Lu Y, Wang S, Ma D.

Cancer Lett. 2008 Mar 8;261(1):55-63.

PMID:
18155831
16.

The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.

Kanou T, Oneyama C, Kawahara K, Okimura A, Ohta M, Ikeda N, Shintani Y, Okumura M, Okada M.

Mol Cancer Res. 2011 Jan;9(1):103-14. doi: 10.1158/1541-7786.MCR-10-0340.

17.

c-Src-mediated epithelial cell migration and invasion regulated by PDZ binding site.

Baumgartner M, Radziwill G, Lorger M, Weiss A, Moelling K.

Mol Cell Biol. 2008 Jan;28(2):642-55.

18.
19.

Supplemental Content

Support Center